XtalPi
Combines quantum physics, artificial intelligence, and robotics for molecule discovery.
What they do
XtalPi provides an integrated platform combining cloud-based quantum physics algorithms, machine learning, and automated robotic wet-labs. Pharmaceutical and materials science enterprises purchase their platform services to predict crystal structures and optimize the development of solid-state drug formulations.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Public
- Headquarters
- Shenzhen, China
- Region
- Asia-Pacific
- Founded
- 2014
- Total funding
- $786M raised
Notable investors: Tencent Holdings, Sequoia Capital China, SoftBank Vision Fund, 5Y Capital.